Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Cash (2019 - 2025)

Benitec Biopharma has reported Change in Cash over the past 7 years, most recently at $94.3 million for Q4 2025.

  • Quarterly results put Change in Cash at $94.3 million for Q4 2025, up 655.55% from a year ago — trailing twelve months through Dec 2025 was $138.0 million (up 351.77% YoY), and the annual figure for FY2025 was $46.9 million, down 3.12%.
  • Change in Cash reached $94.3 million in Q4 2025 per BNTC's latest filing, up from -$3.3 million in the prior quarter.
  • Across five years, Change in Cash topped out at $94.3 million in Q4 2025 and bottomed at -$17.0 million in Q4 2024.
  • Median Change in Cash over the past 5 years was -$3.4 million (2021), compared with a mean of $9.2 million.
  • Peak annual rise in Change in Cash hit 1002.4% in 2024, while the deepest fall reached 209.27% in 2024.
  • Over 5 years, Change in Cash stood at -$3.4 million in 2021, then tumbled by 76.46% to -$6.0 million in 2022, then grew by 8.46% to -$5.5 million in 2023, then plummeted by 209.27% to -$17.0 million in 2024, then soared by 655.55% to $94.3 million in 2025.
  • Business Quant data shows Change in Cash for BNTC at $94.3 million in Q4 2025, -$3.3 million in Q3 2025, and $46.9 million in Q2 2025.